Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine effect on hedonic food intake
NCT04005768Phase 4Unknown
- Sponsor
- UZ Leuven
- Start
- Aug 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in obesity comparing Hydroxychloroquine Sulphate with Placebo (2 arms). Primary endpoint: Hedonic food intake. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04005768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04005768.